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GWAS data generation and quality control 
ALSPAC children were genotyped using the Illumina HumanHap550 quad chip 
genotyping platforms. The resulting raw genome-wide data were subjected to 
standard quality control methods. Individuals were excluded on the basis of gender 
mismatches; minimal or excessive heterozygosity; disproportionate levels of 
individual missingness (>3%) and insufficient sample replication (IBD < 0.8). 
Population stratification was assessed by multidimensional scaling analysis and 
compared with Hapmap II (release 22) European descent (CEU), Han Chinese, 
Japanese and Yoruba reference populations; all individuals with non-European 
ancestry were removed. SNPs with a minor allele frequency of < 1%, a call rate of < 
95% or evidence for violations of Hardy-Weinberg equilibrium (P < 5E-7) were 
removed. Cryptic relatedness was measured as proportion of identity by descent 
(IBD > 0.1). Related subjects that passed all other quality control thresholds were 
retained during subsequent phasing and imputation. 9,115 subjects and 500,527 
SNPs passed these quality control filters. 
ALSPAC mothers were genotyped using the Illumina human660W-quad array at 
Centre National de Génotypage (CNG) and genotypes were called with Illumina 
GenomeStudio. PLINK (v1.07) was used to carry out quality control measures on an 
initial set of 10,015 subjects and 557,124 directly genotyped SNPs. SNPs were 
removed if they displayed more than 5% missingness or a Hardy-Weinberg 
equilibrium P value of less than 1.0e-06. Additionally, SNPs with a minor allele 
frequency of less than 1% were removed. Samples were excluded if they displayed 
more than 5% missingness, had indeterminate X chromosome heterozygosity or 
extreme autosomal heterozygosity. Samples showing evidence of population 
stratification were identified by multidimensional scaling of genome-wide identity by 
state pairwise distances using the four HapMap populations as a reference, and then 
excluded. Cryptic relatedness was assessed using a IBD estimate of more than 
0.125 which is expected to correspond to roughly 12.5% alleles shared IBD or a 
relatedness at the first cousin level. Related subjects that passed all other quality 
control thresholds were retained during subsequent phasing and imputation. 9,048 
subjects and 526,688 SNPs passed these quality control filters. 
After combining genotype data in the mothers and the children, SNPs with genotype 
missingness above 1% were removed due to poor quality (11,396 SNPs removed) 
and a further 321 subjects were removed due to potential ID mismatches. This 
resulted in a dataset of 17,842 subjects. Imputation of the target data was performed 
using Impute V2.2.2 against the 1000 genomes reference panel (Phase 1, Version 3) 
(all polymorphic SNPs excluding singletons), using all 2186 reference haplotypes 
(including non-Europeans). 
This gave 8,237 eligible children and 8,196 eligible mothers with available genotype 
data after exclusion of related subjects using cryptic relatedness measures 
described previously. 




We used the PRSice software (http://prsice.info/) to generate polygenic scores for 
each trait within the ALSPAC genome-wide data. PRSice performs linkage 
disequilibrium clumping based on SNPs available in both GWAS and target datasets. 
We excluded SNPs with an R2 of >0.1, which were within 250Kb of each other. SNPs 
located in the extended MHC region (chromosome 6 (26-33Mb)) were excluded. We 
used the following p-value thresholds to define polygenic scores: 0.0005, 0.005, 
0.05, 0.1, 0.5. Analyses were performed separately in mothers and children using 
bestguess genotypes generated from the imputed data, filtered on a minor allele 
frequency >0.01 and imputation quality of >0.8.    
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1 8-42 weeks gestation 17-18 years 4 weeks 65 months 7 years 
2 12 weeks gestation  6 months 69 months 8 years 
3 18 weeks gestation  15 months 73 months 9 years 
4 32 weeks gestation  18 months 77 months 10 + years 
5 8 weeks  24 months 81 months 11 + years 
6 8 months  30 months 85 months 13 years 
7 21 months  38 months 91 months 14 years 
8 33 months  42 months 97 months 15 years 
9 47 months  54 months 103 months 18 years 
10 61 months  57 months 110 months  
11 85 months  65 months 115 months  
12 73 months  69 months 122 months  
13 97 months  77 months 128 months  
14 110 months  81 months 134 months  
15 122 months  91 months 140 months  
16 134 months  103 months 145 months  
17 145 months  103 months 157 months  
18 18 years +  115 months 157 months  
19 19 years +  128 months 166 months  
20   140 months 167 months  
21   157 months 169 months  
22   166 months 198 months  
23   198 months 18 years  
24   19 years + 20 years  
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Table S2. Description of polygenic risk scores 
Trait Reference  Data available at:  





Wood et al. (2) http://portals.broadinstitute.org/collaboration/giant/index
.php/GIANT_consortium_data_files 
Smoking initiation Furberg et al. (3) https://www.med.unc.edu/pgc 
Education Okbay et al. (4) https://www.thessgac.org/data 
Sleep Jones et al. (5)  http://www.t2diabetesgenes.org/data/ 
Morningness Jones et al. (5) http://www.t2diabetesgenes.org/data/ 
Age at Menarche Perry et al. (6)  http://www.reprogen.org/data_download.html 
Depression Okbay et al. (7) https://www.thessgac.org/data 
Schizophrenia  Schizophrenia  working group of Psychiatric Genomics Consortium (8) https://www.med.unc.edu/pgc 
ADHD 
Psychiatric Genomics Consortium (PGC) and the Lundbeck Foundation 
Initiative for Integrative Psychiatric Research (iPSYCH) (9) 
https://www.med.unc.edu/pgc 
Bipolar  
Cross-Disorder Group of the Psychiatric Genomics Consortium (10) Autism 







Lambert et al. (12) http://web.pasteur-
lille.fr/en/recherche/u744/igap/igap_download.php 
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Table S3 Genomewide scores for traits generate in PRSice 
Trait  Number of independent genomewide SNPs in  
original GWAS paper 
Number in score 
generate using  
PRSice 
Years of Education  74 64 
BMI 77 (in Europeans) 72 
Smoking initiation  1 1 
Morningness  11 (in discovery sample which were replicated) 7 
Sleep  3  2 
Age at menarche 123 108 
Alzheimer’s  19 (in discovery sample which were replicated) 18 
ADHD 12 (in full ADHD GWAS) 8 
Depression  2 2 
Schizophrenia 128 95 
Height 697 535 
Autism 1 1 
Bipolar 4 4 
Conscientiousness 1 1 
Openness 2 1 
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Table S4 Dichomisation point for sensitivity analyses using continuous variables   
Individual Metric Model Dichotomisation point 
Mother Mother questionnaire Logistic 12 
Total questionnaire 30 
Total participation 30 
Most recent clinic NA 
Most recent questionnaire NA 
Child Child questionnaire Logistic 5 
Total questionnaire 30 
Total participation 30 
Child clinic 4 
Most recent clinic NA 
Most recent questionnaire NA 
 
  




Table S5. Comparison of analysis sample with full sample.   
 Mother Child 








  Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Total Participation 50.6 (23.8)  44.0 (25.5) 53.5 (22.0) 44.0 (25.4) 
Total Questionnaire 45.0 (20.7)  39.5 (22.2)    47.4 (19.2) 39.4 (22.2) 
Mother Questionnaire 14.0 (5.2)  12.7 (5.7) -  - 
Child Questionnaire - - 14.8 (8.0) 11.7 (8.8) 
Child Clinic - - 5.7 (3.4) 4.2 (3.7) 
 N (%) N (%) N (%) N (%) 
Mother attended most recent clinic 3,215 (43.0)   4,634 (33.6) - - 
Mother completed most recent 
questionnaire 
3,052 (40.8) 4,468 (32.4) - - 
Child attended most recent clinic -  3,538 (47.1) 4,878 (35.0) 
Child completed most recent 
questionnaire 
-  2,957 (39.4) 4,147 (29.7) 























 Child Mother  










Total  1    Total  1   
Total questionnaire 0.9867 1   Total questionnaire 0.9877 1  
Child questionnaire 0.9505 0.9611 1  Mother questionnaire 0.9379 0.948 1 
Child clinic 0.8093 0.7202 0.7193 1     
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Table S7. Pearson’s correlation coefficients between genetic risk scores generated at p<0.5 in the ALSPAC mothers (N=7,468) 
 
BMI Morning Sleep Smoking Education Autism Schiz Dep BPD ADHD Alzh Agreeable Consc Extraversion Neuroticism Open Height Menarche
BMI 1
Morningness 0.0171 1
Sleep -0.0029 -0.0071 1
Smoking 0.0386 -0.0073 -0.0126 1
Education -0.1332 -0.0383 0.0222 -0.0499 1
Autism -0.014 -0.0108 -0.0073 0.002 0.0418 1
Schizophrenia -0.0041 -0.0207 0.0199 0.0935 0.0426 0.0128 1
Depression 0.0518 -0.0725 -0.0502 0.0437 -0.1136 0.0025 0.0518 1
Bipolar disorder -0.005 -0.0275 0.0073 0.0128 0.0446 0.0132 0.1716 0.0476 1
ADHD -0.0066 -0.0047 0.0046 0.0282 -0.0312 0.0253 0.0325 0.0148 0.0334 1
Alzheimer's disease 0.0106 0.0143 -0.0069 -0.0037 -0.0309 -0.0211 0.0257 0.0024 0.0061 -0.0029 1
Agreeableness -0.0208 -0.0226 -0.0007 -0.0277 0.0465 0.0094 -0.0105 -0.0272 0.0101 0.0035 0.0031 1
Conscientiousness 0.0096 0.0353 -0.0058 -0.0698 -0.0101 -0.0156 -0.0292 -0.0109 -0.0301 -0.0074 0.0139 0.2143 1
Extraversion 0.02 0.0053 0.0094 0.0233 0.0075 -0.002 0.0345 -0.0149 0.0004 0.0083 0.0032 0.2388 0.3295 1
Neuroticism -0.0191 -0.0025 0.0018 -0.0027 -0.0173 0.0021 -0.0001 0.0252 -0.0057 -0.0052 -0.012 -0.2269 -0.2966 -0.4009 1
Openness 0.0012 -0.0175 0.0108 0.0226 0.0577 0.0325 0.0527 0.0013 0.0138 0.0048 -0.012 0.071 -0.0377 0.1542 -0.0859 1
Height -0.109 0.0099 -0.0033 -0.1056 0.0517 -0.0038 -0.0952 -0.012 -0.0298 -0.0168 -0.0097 0.0091 0.0406 -0.0208 -0.0501 -0.0321 1
Age at menarche -0.1544 0.0014 0.0232 0.0219 0.0363 0.021 0.0308 -0.0229 0.0051 -0.0182 0.0049 0.0134 0.0084 0.0175 -0.029 -0.0257 0.0743 1
Supplementary Material: genetics of participation 
10 
 
Table S8. Pearson’s correlation coefficients between genetic risk scores generated at p<0.0005 in the ALSPAC mothers (N=7,468) 
 
BMI Morning Sleep Smoking Education Autism Schiz Dep BPD ADHD Alzh Agreeable Consc Extraversion Neuroticism Open Height Menarche
BMI 1
Morningness -0.0005 1
Sleep 0.0134 -0.0146 1
Smoking -0.0005 0.0022 -0.0043 1
Education -0.0784 -0.023 0.0036 -0.0097 1
Autism 0 -0.0447 -0.0316 0.0207 0.0437 1
Schizophrenia 0.0138 -0.0121 0.0737 0.0199 0.0392 -0.0228 1
Depression -0.0077 -0.0162 -0.0299 0.0144 -0.0363 0.0224 0.0236 1
Bipolar disorder 0.0005 -0.0144 -0.002 0.005 0.0482 -0.0047 0.0897 0.0204 1
ADHD -0.015 -0.004 0.0033 0.0077 -0.0075 -0.0088 0.006 0.0004 0.0149 1
Alzheimer's disease -0.0144 0.0141 -0.0005 -0.0113 -0.0196 -0.0098 0.0144 -0.0096 -0.0012 0.0048 1
Agreeableness 0.0215 -0.0119 -0.0152 -0.0125 0.0058 -0.0072 0.0091 -0.0127 -0.0039 0.0006 -0.0085 1
Conscientiousness 0.0243 -0.0009 0.006 0.0086 -0.0142 0.0015 0.0043 0.0023 -0.0059 -0.0083 -0.0009 0.0118 1
Extraversion 0.0098 -0.0027 -0.002 -0.0158 -0.0016 -0.0057 0.0095 0.0083 0.0016 0.001 0.009 0.0116 0.049 1
Neuroticism -0.0197 0.0037 -0.0014 0.0116 -0.0137 0.0122 -0.0032 0.0032 -0.0008 0.0011 -0.014 -0.0103 -0.0456 -0.0556 1
Openness 0.0122 -0.0045 -0.0234 -0.0175 0.0389 -0.0044 0.0169 -0.0119 -0.009 -0.0021 -0.0023 0.0023 -0.0181 -0.008 -0.0025 1
Height -0.043 -0.0074 -0.019 0.0015 0.0589 0.0162 -0.0235 0.0004 0.0079 0.0238 0.023 -0.0011 -0.0197 0.008 -0.0102 0.0121 1
Age at menarche -0.1074 -0.0049 -0.005 0.0108 -0.0234 -0.023 -0.0119 -0.008 0.0123 -0.0211 0.0133 -0.0042 -0.0153 0.0116 0.0001 0.0104 0.0365 1
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Table S9. Pearson’s correlation coefficients between genetic risk scores generated at p<0.5 in the ALSPAC children (N=7,508) 
 
 







BMI Morning Sleep Smoking Education Autism Schiz Dep BPD ADHD Alzh Agreeable Consc Extraversion Neuroticism Open Height
BMI 1
Morningness 0.0404 1
Sleep 0.0015 -0.0012 1
Smoking 0.0412 -0.0002 -0.0028 1
Education -0.1207 -0.0362 0.0421 -0.0524 1
Autism -0.007 0.007 0.0125 0.02 0.0541 1
Schizophrenia -0.0072 0.0031 0.0385 0.0651 0.0374 0.0068 1
Depression 0.0441 -0.0614 -0.0657 0.0634 -0.1184 0.0235 0.0225 1
Bipolar disorder -0.0204 -0.0263 0.021 0.0125 0.055 -0.0033 0.1616 0.0165 1
ADHD -0.0006 0.0072 0.0047 0.0316 -0.0196 0.01 0.0155 -0.0029 0.028 1
Alzheimer's disease 0.0116 0.0143 0.0064 0.012 -0.0367 -0.0041 0.0211 0.0006 0.0254 -0.0187 1
Agreeableness -0.0194 0.0167 0.0088 -0.0159 0.0403 -0.0069 -0.0186 -0.031 0.0243 -0.0339 0.0097 1
Conscientiousness 0.0035 0.0051 -0.0028 -0.0447 -0.0079 -0.0101 -0.0208 -0.0042 -0.012 -0.0275 0.0211 0.2321 1
Extraversion 0.0117 0.01 0.0031 0.0326 0.0146 -0.0012 0.0201 -0.0113 0.014 0.0062 0.0343 0.2165 0.3293 1
Neuroticism 0.0009 0.0103 -0.0174 -0.0158 -0.0245 0.0048 0.0075 0.0282 -0.0182 -0.005 -0.0026 -0.2218 -0.283 -0.3859 1
Openness 0.0192 -0.0045 0.0017 0.0429 0.0693 0.0238 0.0398 -0.0034 0.0175 0.0218 -0.0151 0.0734 -0.052 0.1504 -0.076 1
Height -0.1182 -0.0154 0.0032 -0.0924 0.036 0.0051 -0.0713 -0.0342 -0.0299 -0.0237 -0.0153 0.0123 0.0452 -0.0095 -0.0862 -0.077 1
BMI Morning Sleep Smoking Education Autism Schiz Dep BPD ADHD Alzh Agreeable Consc Extraversion Neuroticism Open Height
Menarche (0.05) -0.1736 -0.0088 0.0117 0.0171 0.0249 0.0067 0.0162 -0.0373 -0.0013 -0.0077 0.0185 -0.0146 0.0187 -0.005 0.0124 -0.042 0.0745
Supplementary Material: genetics of participation 
12 
 
Table S10. Pearson’s correlation coefficients between genetic risk scores generated at p<0.0005 in the ALSPAC children (N=7,508) 
 
 
Correlations with age at menarche in females (N=3,639) 
BMI Morning Sleep Smoking Education Autism Schiz Dep BPD ADHD Alzh Agreeable Consc Extraversion Neuroticism Open Height
BMI 1
Morningness 0.0108 1
Sleep 0.0112 0.011 1
Smoking -0.005 -0.0016 0.0151 1
Education -0.0491 -0.0081 0.0254 -0.0297 1
Autism -0.0208 -0.0194 -0.0635 -0.008 0.0349 1
Schizophrenia 0.0119 0.0007 0.0698 0.0365 0.0181 -0.0225 1
Depression -0.0067 -0.0325 -0.0444 -0.0017 -0.0306 0.027 0.0208 1
Bipolar disorder -0.0122 -0.0043 -0.0055 0.0126 0.0247 0.0014 0.1024 -0.003 1
ADHD -0.0035 -0.0003 0.015 -0.0047 -0.0008 -0.0115 -0.0085 -0.0041 -0.0034 1
Alzheimer's disease 0.0008 0.0027 -0.0107 0.0027 -0.0181 -0.0026 0.0105 -0.0088 -0.0034 0.0008 1
Agreeableness -0.0071 -0.0074 -0.0031 -0.0097 0.0195 -0.0113 -0.0099 -0.0057 -0.0006 -0.0111 0.0078 1
Conscientiousness 0.0054 0.009 0.0095 -0.0026 -0.0024 -0.0126 -0.0077 -0.0101 -0.0035 -0.0226 0.0083 0.0389 1
Extraversion 0.0143 0.0024 0.0097 0.013 -0.0156 0.0019 0.0146 -0.0071 -0.0226 0.0037 0.0015 0.0284 0.0489 1
Neuroticism -0.028 -0.0372 -0.002 -0.0065 -0.0076 0.0089 -0.0008 0.0137 0.0057 0.0175 -0.0325 -0.009 -0.057 -0.0679 1
Openness 0.0035 -0.0184 -0.0143 -0.008 0.0257 0.0005 0.0253 -0.021 0.004 -0.0173 0.0184 -0.0191 0.0064 0.0067 0.0125 1
Height -0.0402 -0.0222 -0.0055 -0.0163 0.0589 0.0101 -0.0306 -0.0293 0.0046 0.0257 0.0134 0 -0.023 0.0321 -0.0123 -0.02 1
BMI Morning Sleep Smoking Education Autism Schiz Dep BPD ADHD Alzh Agreeable Consc Extraversion Neuroticism Open Height
Menarche (0.0005) -0.1304 -0.0086 -0.0005 0.0091 -0.023 -0.0029 0.0323 -0.0233 0.0412 -0.0082 -0.0013 -0.0289 0.0085 -0.0023 0.0022 -0.029 0.038
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Table S11. Genomewide significant associations with total participation in mothers 
 
SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs10626545 7 51999752 TCA T 10.97 1.81 1.50E-09 0.987 0.94 
rs406001 7 52006415 C T 10.86 1.80 1.67E-09 0.988 1.00 
rs10234957 7 52011171 A G 10.83 1.81 2.12E-09 0.988 1.00 
rs10265236 7 52011178 T C 10.83 1.81 2.12E-09 0.988 1.00 
rs392252 7 52039815 G A 10.84 1.81 2.15E-09 0.988 1.00 
rs413648 7 52013580 G T 10.81 1.81 2.23E-09 0.988 1.00 
rs403531 7 52007845 G A 10.81 1.81 2.23E-09 0.988 1.00 
rs616199 7 52014884 C A 10.81 1.81 2.23E-09 0.988 1.00 
rs428360 7 52015414 A T 10.81 1.81 2.23E-09 0.988 1.00 
rs410473 7 52015969 A G 10.81 1.81 2.24E-09 0.988 1.00 
rs382903 7 52033199 A G 10.81 1.81 2.24E-09 0.988 1.00 
rs377851 7 52031652 T A 10.81 1.81 2.24E-09 0.988 1.00 
rs364752 7 52021977 T C 10.81 1.81 2.25E-09 0.988 1.00 
rs417388 7 52029191 T C 10.81 1.81 2.25E-09 0.988 1.00 
rs454526 7 52030332 C A 10.81 1.81 2.25E-09 0.988 1.00 
rs411093 7 52007969 C T 10.81 1.81 2.26E-09 0.988 1.00 
rs411481 7 52008508 G A 10.81 1.81 2.26E-09 0.988 1.00 
rs402450 7 52008755 A G 10.81 1.81 2.26E-09 0.988 1.00 
rs455017 7 52002774 C T 10.86 1.82 2.27E-09 0.988 0.99 
rs396471 7 52005401 G T 10.84 1.81 2.28E-09 0.988 1.00 
rs590600 7 52004473 A T 10.85 1.81 2.30E-09 0.988 0.99 
rs384551 7 52001102 A G 10.86 1.82 2.31E-09 0.988 0.99 
rs409776 7 52001673 T G 10.86 1.82 2.31E-09 0.988 0.99 
rs408595 7 52000754 C T 10.86 1.82 2.31E-09 0.988 0.99 
rs608826 7 52000958 G A 10.86 1.82 2.32E-09 0.988 0.99 
rs438867 7 51999538 T C 10.87 1.82 2.32E-09 0.988 0.99 
rs382727 7 51998920 C T 10.87 1.82 2.33E-09 0.988 0.99 
rs379235 7 51998152 A T 10.87 1.82 2.33E-09 0.988 0.99 
rs426522 7 51997533 T C 10.87 1.82 2.34E-09 0.988 0.99 
rs454404 7 51996191 C T 10.99 1.84 2.46E-09 0.989 0.98 
rs452777 7 51995163 C T 10.99 1.84 2.50E-09 0.989 0.98 
rs10480946 7 52009321 C T 10.70 1.80 2.64E-09 0.988 0.99 
rs6971505 7 52009980 A T 10.90 1.86 5.14E-09 0.989 1.00 
rs400204 7 52014571 A G 10.90 1.86 5.15E-09 0.989 1.00 
rs424283 7 52023670 A G 10.90 1.86 5.16E-09 0.989 1.00 
rs201492164 7 51999316 T TTG 10.44 1.81 8.08E-09 0.988 0.96 
rs664926 7 52016205 A T 10.02 1.74 8.17E-09 0.987 1.00 
rs647653 7 52042739 C T 9.67 1.73 2.07E-08 0.987 0.99 
rs428955 7 52042976 T A 9.54 1.73 3.24E-08 0.987 0.97 
rs201423711 7 51999664 AT A 8.77 1.59 3.52E-08 0.981 0.81 
rs11405039 7 51999666 TG T 8.77 1.59 3.52E-08 0.981 0.81 
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Table S12. Genomewide significant associations with total questionnaire in mothers 
SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs10626545 7 51999752 TCA T 9.65 1.57 8.55E-10 0.987 0.94 
rs406001 7 52006415 C T 9.53 1.56 1.05E-09 0.988 1.00 
rs392252 7 52039815 G A 9.55 1.57 1.22E-09 0.988 1.00 
rs10234957 7 52011171 A G 9.51 1.56 1.27E-09 0.988 1.00 
rs10265236 7 52011178 T C 9.51 1.56 1.27E-09 0.988 1.00 
rs382903 7 52033199 A G 9.50 1.57 1.34E-09 0.988 1.00 
rs413648 7 52013580 G T 9.50 1.57 1.34E-09 0.988 1.00 
rs377851 7 52031652 T A 9.50 1.57 1.35E-09 0.988 1.00 
rs403531 7 52007845 G A 9.50 1.57 1.35E-09 0.988 1.00 
rs616199 7 52014884 C A 9.50 1.57 1.35E-09 0.988 1.00 
rs428360 7 52015414 A T 9.50 1.57 1.35E-09 0.988 1.00 
rs410473 7 52015969 A G 9.50 1.57 1.35E-09 0.988 1.00 
rs364752 7 52021977 T C 9.50 1.57 1.36E-09 0.988 1.00 
rs417388 7 52029191 T C 9.50 1.57 1.36E-09 0.988 1.00 
rs454526 7 52030332 C A 9.50 1.57 1.36E-09 0.988 1.00 
rs455017 7 52002774 C T 9.55 1.57 1.36E-09 0.988 0.99 
rs411093 7 52007969 C T 9.50 1.57 1.36E-09 0.988 1.00 
rs411481 7 52008508 G A 9.50 1.57 1.36E-09 0.988 1.00 
rs402450 7 52008755 A G 9.50 1.57 1.36E-09 0.988 1.00 
rs396471 7 52005401 G T 9.53 1.57 1.37E-09 0.988 1.00 
rs590600 7 52004473 A T 9.54 1.57 1.38E-09 0.988 0.99 
rs384551 7 52001102 A G 9.55 1.58 1.38E-09 0.988 0.99 
rs409776 7 52001673 T G 9.55 1.57 1.38E-09 0.988 0.99 
rs408595 7 52000754 C T 9.55 1.58 1.38E-09 0.988 0.99 
rs608826 7 52000958 G A 9.55 1.58 1.39E-09 0.988 0.99 
rs10480946 7 52009321 C T 9.44 1.56 1.39E-09 0.988 0.99 
rs438867 7 51999538 T C 9.55 1.58 1.39E-09 0.988 0.99 
rs382727 7 51998920 C T 9.55 1.58 1.39E-09 0.988 0.99 
rs379235 7 51998152 A T 9.56 1.58 1.39E-09 0.988 0.99 
rs426522 7 51997533 T C 9.56 1.58 1.39E-09 0.988 0.99 
rs454404 7 51996191 C T 9.67 1.60 1.43E-09 0.989 0.98 
rs452777 7 51995163 C T 9.67 1.60 1.46E-09 0.989 0.98 
rs6971505 7 52009980 A T 9.71 1.62 1.99E-09 0.989 1.00 
rs400204 7 52014571 A G 9.71 1.62 1.99E-09 0.989 1.00 
rs424283 7 52023670 A G 9.71 1.62 2.00E-09 0.989 1.00 
rs201492164 7 51999316 T TTG 9.18 1.57 4.96E-09 0.988 0.96 
rs664926 7 52016205 A T 8.77 1.51 5.90E-09 0.987 1.00 
rs647653 7 52042739 C T 8.53 1.50 1.18E-08 0.987 0.99 
rs428955 7 52042976 T A 8.42 1.50 1.82E-08 0.987 0.97 
rs201423711 7 51999664 AT A 7.76 1.38 1.87E-08 0.981 0.81 
rs11405039 7 51999666 TG T 7.76 1.38 1.87E-08 0.981 0.81 
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Table S13. Genomewide significant associations with mother questionnaire in mothers 
SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs406001 7 52006415 C T 2.27 0.39 8.27E-09 0.988 1.00 
rs392252 7 52039815 G A 2.27 0.40 9.84E-09 0.988 1.00 
rs10234957 7 52011171 A G 2.26 0.39 9.92E-09 0.988 1.00 
rs10265236 7 52011178 T C 2.26 0.39 9.92E-09 0.988 1.00 
rs413648 7 52013580 G T 2.26 0.39 1.07E-08 0.988 1.00 
rs382903 7 52033199 A G 2.26 0.39 1.07E-08 0.988 1.00 
rs403531 7 52007845 G A 2.26 0.39 1.07E-08 0.988 1.00 
rs616199 7 52014884 C A 2.26 0.39 1.07E-08 0.988 1.00 
rs377851 7 52031652 T A 2.26 0.39 1.07E-08 0.988 1.00 
rs428360 7 52015414 A T 2.26 0.39 1.07E-08 0.988 1.00 
rs410473 7 52015969 A G 2.26 0.39 1.07E-08 0.988 1.00 
rs364752 7 52021977 T C 2.26 0.39 1.08E-08 0.988 1.00 
rs417388 7 52029191 T C 2.26 0.39 1.08E-08 0.988 1.00 
rs454526 7 52030332 C A 2.26 0.39 1.08E-08 0.988 1.00 
rs411093 7 52007969 C T 2.26 0.39 1.08E-08 0.988 1.00 
rs411481 7 52008508 G A 2.26 0.39 1.08E-08 0.988 1.00 
rs402450 7 52008755 A G 2.26 0.39 1.08E-08 0.988 1.00 
rs10480946 7 52009321 C T 2.25 0.39 1.09E-08 0.988 0.99 
rs455017 7 52002774 C T 2.27 0.40 1.09E-08 0.988 0.99 
rs396471 7 52005401 G T 2.27 0.40 1.09E-08 0.988 1.00 
rs590600 7 52004473 A T 2.27 0.40 1.10E-08 0.988 0.99 
rs384551 7 52001102 A G 2.27 0.40 1.11E-08 0.988 0.99 
rs408595 7 52000754 C T 2.27 0.40 1.11E-08 0.988 0.99 
rs409776 7 52001673 T G 2.27 0.40 1.11E-08 0.988 0.99 
rs608826 7 52000958 G A 2.27 0.40 1.11E-08 0.988 0.99 
rs438867 7 51999538 T C 2.27 0.40 1.11E-08 0.988 0.99 
rs382727 7 51998920 C T 2.27 0.40 1.12E-08 0.988 0.99 
rs379235 7 51998152 A T 2.27 0.40 1.12E-08 0.988 0.99 
rs426522 7 51997533 T C 2.27 0.40 1.12E-08 0.988 0.99 
rs10626545 7 51999752 TCA T 2.26 0.40 1.12E-08 0.987 0.94 
rs454404 7 51996191 C T 2.30 0.40 1.18E-08 0.989 0.98 
rs452777 7 51995163 C T 2.30 0.40 1.20E-08 0.989 0.98 
rs6971505 7 52009980 A T 2.32 0.41 1.33E-08 0.989 1.00 
rs400204 7 52014571 A G 2.32 0.41 1.34E-08 0.989 1.00 
rs424283 7 52023670 A G 2.32 0.41 1.34E-08 0.989 1.00 
rs201492164 7 51999316 T TTG 2.18 0.40 3.63E-08 0.988 0.96 
rs664926 7 52016205 A T 2.07 0.38 4.79E-08 0.987 1.00 
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Table S14. Genomewide significant associations with total participation in children  
SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs28631073 14 96726466 G A -3.20 0.57 2.27E-08 0.11 1.00 
rs10143977 14 96726883 G T -3.19 0.57 2.35E-08 0.11 1.00 
rs10134118 14 96726986 T C -3.18 0.57 2.85E-08 0.11 1.00 
rs11622768 14 96727554 T C -3.17 0.57 3.12E-08 0.11 1.00 
rs10137303 14 96728002 G A -3.15 0.57 3.52E-08 0.11 1.00 
rs10147171 14 96727874 C T -3.14 0.57 4.09E-08 0.11 1.00 
rs4905475 14 96721850 C G -3.16 0.58 4.17E-08 0.11 0.99 
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Table S15. Genomewide significant associations with total questionnaire in children  
SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs28631073 14 96726466 G A -2.83 0.50 1.53E-08 0.11 1.00 
rs10143977 14 96726883 G T -2.82 0.50 1.59E-08 0.11 1.00 
rs10134118 14 96726986 T C -2.81 0.50 1.96E-08 0.11 1.00 
rs11622768 14 96727554 T C -2.80 0.50 2.14E-08 0.11 1.00 
rs10137303 14 96728002 G A -2.78 0.50 2.48E-08 0.11 1.00 
rs4905475 14 96721850 C G -2.79 0.50 2.88E-08 0.11 0.99 
rs10147171 14 96727874 C T -2.77 0.50 2.93E-08 0.11 1.00 
rs11628515 14 96728111 A T -2.76 0.50 3.79E-08 0.11 1.00 





Supplementary Material: genetics of participation 
18 
 
Table S16. Genomewide significant associations with child questionnaire in children  
  
SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs28631073 14 96726466 G A -1.18 0.21 1.29E-08 0.11 1.00 
rs10143977 14 96726883 G T -1.18 0.21 1.33E-08 0.11 1.00 
rs10134118 14 96726986 T C -1.17 0.21 1.79E-08 0.11 1.00 
rs11622768 14 96727554 T C -1.16 0.21 2.02E-08 0.11 1.00 
rs10137303 14 96728002 G A -1.16 0.21 2.13E-08 0.11 1.00 
rs10147171 14 96727874 C T -1.15 0.21 2.69E-08 0.11 1.00 
rs4905475 14 96721850 C G -1.16 0.21 2.71E-08 0.11 0.99 
rs11628515 14 96728111 A T -1.14 0.21 3.71E-08 0.11 1.00 
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SNP CHR BP A1 A2 Beta SE P A1_freq info 
rs1336852 1 191752825 G A -0.59 0.11 3.15E-08 0.07 0.98 
rs74626786 1 191759598 G C -0.59 0.11 3.32E-08 0.07 0.98 
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Adjusted for the first 10 genetic principal components. 
 H2 Standard error P-value 
Mother    
Total participation 0.271 0.045 7.00E-11 
Total questionnaire 0.267 0.045 1.53E-19 
Mother questionnaire 0.238 0.044 8.59E-09 
Mother last clinic 0.225 0.045 9.70E-08 
Mother last questionnaire 0.203 0.045 1.46E-06 
    
Child    
Total participation 0.301 0.045 6.05E-13 
Total questionnaire 0.287 0.045 7.03E-12 
Child questionnaire 0.319 0.045 6.06E-14 
Child clinic 0.249 0.044 9.10E-10 
Child last clinic 0.249 0.045 4.00E-09 
Child last questionnaire 0.178 0.045 2.52E-05 
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Figure S2. Flowchart of ALSPAC children included in analysis 
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Figure S6. Associations between polygenic risk scores and attendance at most recent clinic in ALSPAC children (N=7,508) 
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Figure S7. Associations between polygenic risk scores and total questionnaire completion in ALSPAC children (N=7,508) 
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Figure S8. . Associations between polygenic risk scores and child completed questionnnaires in ALSPAC children (N=7,508) 
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Figure S10. Manhattan plots for GWAS of mother last clinic and mother last questionnaire 
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Figure S11. QQ plots for GWAS of total participation, total questionnaire and mother questionnaire in the ALSPAC mothers 
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Figure S12. Manhattan plots for GWAS of participation in children 
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Figure S13. QQ plots for GWAS of total participation, total questionnaire and mother questionnaire in the ALSPAC mothers 
  
A) Total participation, B) Total questionnaire C) Child questionnaire, D) Child clinic 
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Figure S14. Regional plot of genomewide significant locus for mother total participation 
 
The SNP with the second smallest p-value was used as LD information was not available for 
the top SNP. The top SNP in each region is highlighted in purple and the surrounding SNPs 
are colour coded to reflect their LD with this variant. Estimated recombination rates are plotted 
in blue to reflect local LD structure. Regional plots generated using Locus Zoom, Genome 
build= hg19.  
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Figure S15. Regional plot of genomewide significant locus for mother total questionnaire 
 
The SNP with the second smallest p-value was used as LD information was not available for 
the top SNP. The top SNP in each region is highlighted in purple and the surrounding SNPs 
are colour coded to reflect their LD with this variant. Estimated recombination rates are plotted 
in blue to reflect local LD structure. Regional plots generated using Locus Zoom, Genome 
build= hg19.  
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Figure S16. Regional plot of genomewide significant locus for mother questionnaire 
 
 
The top SNP in each region is highlighted in purple and the surrounding SNPs are colour 
coded to reflect their LD with this variant. Estimated recombination rates are plotted in pale 
blue to reflect local LD structure. Regional plots generated using Locus Zoom, Genome build= 
hg19.  
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Figure S17. Regional plot of genomewide significant locus for child clinic attendance 
 
The top SNP in each region is highlighted in purple and the surrounding SNPs are colour 
coded to reflect their LD with this variant. Estimated recombination rates are plotted in pale 
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Figure S18. Regional plot of genomewide significant locus for child total participation 
 
 
The top SNP in each region is highlighted in purple and the surrounding SNPs are colour 
coded to reflect their LD with this variant. Estimated recombination rates are plotted in pale 
blue to reflect local LD structure. Regional plots generated using Locus Zoom, Genome build= 
hg19. 
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Figure S19. Regional plot of genomewide significant locus for child total questionnaire 
 
The top SNP in each region is highlighted in purple and the surrounding SNPs are colour 
coded to reflect their LD with this variant. Estimated recombination rates are plotted in pale 
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Figure S20. Regional plot of genomewide significant locus for child questionnaire 
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